Abstract
Coronary artery disease (CAD) is a type of heart disease with high incidence and mortality in Europe and the United States as well as in Asian countries. miRNA is a kind of regulatory RNA which controls gene expression by binding to complementary sequences of their targets, thus promotes RNA degradation and/or inhibits protein translation. Recent studies showed miRNAs function as key mediators in the pathological process of CAD which supply potential targets for CAD treatment. Expression of several miRNAs is heart-specific and CAD-specific, in addition to the signature that miRNAs are stable in plasma and other body fluids, makes miRNAs potential biomarkers for CAD diagnosis, therapeutic efficacy and prognosis. Here, the review will summarize the development of miRNAs involved in CAD.
Keywords: biomarker, coronary heart disease, diagnosis, miRNA, prognosis.
Current Signal Transduction Therapy
Title:Role of miRNAs in Coronary Artery Disease
Volume: 9 Issue: 3
Author(s): Leixing Xie, Ruikai Du, Jingxue Niu and Hongbin Liu
Affiliation:
Keywords: biomarker, coronary heart disease, diagnosis, miRNA, prognosis.
Abstract: Coronary artery disease (CAD) is a type of heart disease with high incidence and mortality in Europe and the United States as well as in Asian countries. miRNA is a kind of regulatory RNA which controls gene expression by binding to complementary sequences of their targets, thus promotes RNA degradation and/or inhibits protein translation. Recent studies showed miRNAs function as key mediators in the pathological process of CAD which supply potential targets for CAD treatment. Expression of several miRNAs is heart-specific and CAD-specific, in addition to the signature that miRNAs are stable in plasma and other body fluids, makes miRNAs potential biomarkers for CAD diagnosis, therapeutic efficacy and prognosis. Here, the review will summarize the development of miRNAs involved in CAD.
Export Options
About this article
Cite this article as:
Xie Leixing, Du Ruikai, Niu Jingxue and Liu Hongbin, Role of miRNAs in Coronary Artery Disease, Current Signal Transduction Therapy 2014; 9(3) . https://dx.doi.org/10.2174/1574362410666141224210818
DOI https://dx.doi.org/10.2174/1574362410666141224210818 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology Independent Relationship between Serum Osteocalcin and Uric Acid in a Cohort of Apparently Healthy Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression
Recent Patents on CNS Drug Discovery (Discontinued) Statins and Carotid Intima-Media Thickness Reduction: An Up-to-Date Review
Current Medicinal Chemistry Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Relationship Between Inflammation, Insulin Resistance and Type 2 Diabetes: Cause or Effect?
Current Diabetes Reviews The Use of Unsaturated Fatty Acids in Liposomal Form to Get Bread Enriched with ω-3 Fatty Acids
Current Nutrition & Food Science Structural Neuroimaging Findings in Major Depressive Disorder Throughout Aging: A Critical Systematic Review of Prospective Studies
CNS & Neurological Disorders - Drug Targets Hypertension and Concurrent Arrhythmias
Current Pharmaceutical Design Fluoxetine and all other SSRIs are 5-HT<sub>2B</sub> Agonists - Importance for their Therapeutic Effects
Current Neuropharmacology How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
Current Cardiology Reviews Human Saphenous Vein and Coronary Bypass Surgery: Scanning Electron Microscopy of Conventional and ‘No-Touch’ Vein Grafts
Vascular Disease Prevention (Discontinued) Clinical Utility of Acarbose, an α-Glucosidase Inhibitor in Cardiometabolic Disorders
Current Drug Metabolism Experimental Models of Abdominal Aortic Aneurysms: An Overview
Current Pharmaceutical Design Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Matrix Metalloproteinases in Essential Hypertension
Current Topics in Medicinal Chemistry Susceptibility Genes in Hypertension
Current Pharmaceutical Design Risk and Benefit of Statins in Stroke Secondary Prevention
Current Vascular Pharmacology Down Regulation of Differentiated Embryo-Chondrocyte Expressed Gene 1 is Related to the Decrease of Osteogenic Capacity
Current Drug Targets